L107 Orodispersible tab 2Blister PVC/PVDC/Alu/20

Arsenicum album 6 DH...........................................................................................................................3,125 mg

Belladonna 3 DH......................................................................................................................................3,125 mg

Chamomilla vulgaris 9 DH......................................................................................................................3,125 mg

China rubra 3 DH.....................................................................................................................................3,125 mg

Colocynthis 4 DH.....................................................................................................................................3,125 mg

Ipeca 4 DH................................................................................................................................................3,125 mg

Mercurius corrosivus 6 DH.....................................................................................................................3,125 mg

Nux vomica 4 DH.....................................................................................................................................3,125 mg

for one orodispersible tablet of 250 mg

Excipients with known effect: lactose, mannitol. One tablet contains 136,74 mg of lactose and 106,75 mg of mannitol.

Homeopathic medicine traditionally used as adjuvant treatment of acute gastroenteritis.

Dosage

Reserved for adults and children over 30 months.

Adults: 1 tablet after each liquid stool, space out according to improvement (maximum 6 tablets per day).

In the absence of improvement within 48 hours, medical advice is required.

Children from 30 months, on medical advice only: 1 tablet after each liquid stool, space out according to improvement (maximum 3 tablets per day).

Method of administration

Allow the tablet to dissolve under the tongue, preferably outside meals.

In children under 6 years, dissolve the tablet in a little water before taking it because of the risk of choking.

Space out the intakes as soon as improvement occurs and stop taking when the symptoms disappear.

Treatment should not exceed 5 days.

Sublingual route.

• Children under 30 months of age.
• Hypersensitivity to the active substances or to any of the excipients listed in section Composition.

• In children, the diagnosis, initiation and follow-up of treatment for acute gastroenteritis must be ensured by the physician.
• This medicinal product contains lactose. Its use is not recommended in patients with galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption syndrome (rare hereditary diseases).

In the absence of experimental and clinical data, and as a precaution, use of this medicine should be avoided during pregnancy and breastfeeding.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Centres of Pharmacovigilance - Website: www.ansm.sante.fr.

Pharmacotherapeutic class: homeopathic medicine.

In the absence of scientific data, the indication of this medicine is based on the traditional homeopathic use of its components.

5 years

Store at a temperature not exceeding 30°C.

No special requirements.